📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CYP3A4*22 and bleeding risk in ticagrelor users. (2024)

First Author: Asiimwe IG

Attributed to: Multimorbidity Mechanism and Therapeutics Research Collaborative funded by SPF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bcpt.13977

PubMed Identifier: 38163812

Publication URI: http://europepmc.org/abstract/MED/38163812

Type: Journal Article/Review

Volume: 134

Parent Publication: Basic & clinical pharmacology & toxicology

Issue: 3

ISSN: 1742-7835